To stay up to date with the latest news in dermatology, sign up for our newsletter. E-newsletter.
AI Scribes Part 2: Clinicians want better tools
Healthcare professionals are aware of the growing need for cutting-edge technologies in modern medical practice.
Protection against malpractice liability: Insurance as the first line of defense
David Mandell, JD, MBA, explained that when trying to protect yourself from medical malpractice liability, insurance is certainly the first and most important line of defense.
Q&A: Pelage’s new PP405 reaches Phase 2a for androgenetic alopecia
Qing Yu Christina Weng, MD, provides insights into the further development of the drug following preliminary Phase 1 results.
Wearable sensors could revolutionize AD management
Researchers said integrating wearable sensors with AI could potentially revolutionize the treatment of patients with atopic dermatitis.
Study reveals unique protein profile in Elevai exosomes
Preliminary data suggest that the exosomes could effectively treat common skin problems such as firmness, photodamage and fine wrinkles.
Some dermatological conditions require additional care and referral to specialized medical facilities
Researchers examined referral patterns from a primary dermatology clinic in Japan.
I used botulinum toxin for migraines – now I’ve been sued
According to David Goldberg, MD, JD, the use of drugs and devices for conditions not otherwise indicated is common among physicians and is not generally considered experimental or investigational.
In Europe, people with atopic dermatitis suffer from impairments in their sense of happiness compared to other diseases
Both patients with Alzheimer’s disease and psoriasis report lower levels of satisfaction than the general population.
Individual vitiligo care for each patient: Part 2
Latanya Benjamin, MD, FAAD, reviewed a case study of a 35-year-old woman with a 10-year history of vitiligo and concurrent atopic dermatitis
Apremilast now available in the US for use in children
The availability is notable as it introduces the first oral treatment option for young psoriasis patients.
Weight change during isotretinoin treatment of acne vulgaris not statistically significant
When given at the correct dosage, researchers found insignificant changes in patients’ BMI or markers of metabolic syndrome.
Advances in laser treatment are changing skin rejuvenation
A review found that repeated laser treatments show cumulative benefits, including improved collagen density and skin elasticity over time.
Evaluation of electrical impedance dermography as a tool for the treatment and diagnosis of skin diseases
Researchers believe that promising study results justify further exploration of EID potential on a larger scale.
Study report: Doctors should consider lifestyle changes over time when treating acne vulgaris
After a period of six weeks, most patients showed improvement. Taking the medication daily resulted in an improved quality of life and less skin picking.
Ocular side effects of dupilumab occur more frequently in AD patients than in asthma patients
The study found that 95.8% of ocular adverse events occurred in AD patients, while only 4.2% of these events occurred in SA patients.
Journal Digest: August 21
This week’s collection of the latest dermatology studies includes the prevalence of vulvar dermatoses in patients of different ethnic backgrounds, the adaptation of the Mackie melanoma risk stratification tool to a tablet-based patient questionnaire, in siblings diagnosed with hereditary sensory and autonomic neuropathy, and more.
New report highlights health disparities in psoriasis treatment
The National Psoriasis Foundation’s new report provides an overview of the health impact of psoriasis and highlights significant challenges with treatment and outcomes.
Individual vitiligo care for each patient: Part 3
Anthony Nuara, MD, PhD, reviewed the case study of a 32-year-old professional makeup artist who was concerned that her depigmented areas might affect her livelihood.
There remain significant differences in the skin manifestations, diagnosis and outcomes of scleroderma in people of color
In a review, researchers reported that ethnicity plays a role in disease progression, clinical picture, and more in patients with systemic sclerosis.
Case report shows treatment of refractory follicular lichen planus with ruxolitinib
After treatment with the topical JAK inhibitor, the researchers reported a significant improvement in the damaged skin.
New toolkit aims to promote diversity in skin research
The researchers identified mistrust, social stigma and language barriers as the biggest obstacles for members of ethnic minorities in skin research.
Daily collagen intake delays visible signs of skin and nail aging
A recent study confirmed that collagen peptides effectively counteract age-related skin problems such as reduced density and increasing dryness.
Surgery shows superior efficacy in cutaneous squamous cell carcinoma in situ
A comprehensive analysis of 71 studies found the highest lesion clearance and recurrence rates in people who underwent surgery.
Higher risankizumab adherence with new injection device
According to a recent study, prefilled pens with hidden needles show promise in reducing injection anxiety and improving patient adherence.
GLP-1 agonists are not associated with the development of acne
Some patients reported acne vulgaris as a side effect of GLP-1 receptor agonists.
